Clinical Study Assessing the Safety, Tolerability, and Pharmacokinetics of Intravenous AZD5099 in Healthy Subjects

NCT01340183 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD5099
DRUG: Placebo

Sponsor

AstraZeneca